Your session is about to expire
← Back to Search
Treatment for Cerebroplacental Ratio (CPR Trial)
N/A
Waitlist Available
Led By Todd Rosen, MD
Research Sponsored by Rutgers, The State University of New Jersey
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
* Nulliparous pregnant women between the ages of 18 and 45 years with low risk pregnancies who present for obstetrical ultrasound at 36 weeks of gestation or later with a planned delivery at a Perinatal Research Consortium hospital.
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at the time of delivery
Awards & highlights
Summary
Ultrasound Doppler studies are used during pregnancy to help manage pregnancies complicated by fetal growth restriction. The cerebroplacental ratio may predict adverse outcomes in low risk pregnancies. In a prospective study, the investigators will examine whether fetuses with an abnormal CPR at or near term are at increased risk for being delivered by cesarean,
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ at time of delivery
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at time of delivery
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Cesarean delivery
Secondary study objectives
Apgar scores at 1 and 5 minute
Birthweight/ birthweight percentile
Cases of small for gestational age undetected prenatally
+7 moreFind a Location
Who is running the clinical trial?
Rutgers, The State University of New JerseyLead Sponsor
440 Previous Clinical Trials
64,802 Total Patients Enrolled
Columbia UniversityOTHER
1,471 Previous Clinical Trials
2,535,770 Total Patients Enrolled
Virtua Medical GroupUNKNOWN
1 Previous Clinical Trials
2,408 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger